Learn About New Developments in Asthma on CME Webcast

OSUWexnerbloglogo2014 Learn About New Developments in Asthma on CME Webcast. Today on MedNet, we’re going to tell you about the newest developments in asthma management to help you choose the right medications for your patients. Joining our moderator in the studio to update us on asthma management in adults is pulmonologist and Associate Professor of Internal Medicine, Dr. Jennifer McCallister. And then to update us on asthma management in children is pulmonologist and Associate Professor of Pediatrics, Dr. Elizabeth Allen.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS important safety considerations in the use of long-acting beta-agonists in asthma care; SELECT the most appropriate initial inhaler therapy for a patient with asthma-COPD overlap; IDENTIFY new treatment options for both acute and chronic asthma management; and RECOGNIZE protracted bacterial bronchitis – an asthma mimic in young children.

You’ll also learn about the following:

  • Pathogenesis of asthma
  • Diagnosing asthma in children
  • Equivalency of different brands of inhaled corticosteroids and long-acting beta agonists
  • Asthma medications and pregnancy
  • Allergy testing and desensitization
  • School-based asthma treatment program
  • Exhaled nitric oxide
  • Leukotriene inhibitors in adult asthma
  • Bronchial thermoplasty
  • Peak flow monitoring
  • Role of increasing the dose of inhaled steroids in asthma exacerbations

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Immunosuppressant Medications

OSUWexnerbloglogo2014 CME Webcast Teaches on Immunosuppressant Medications. More and more, primary care physicians and hospitalists are finding themselves taking care of patients who have been started on immunosuppressant medication a transplant physician, rheumatologist, nephrologist, or pulmonologist. On this CME webcast, we’re going to tell you what you need to know about these medications, their side effects, and their complications. Let me introduce our guests. Dr. Brian Keller is a lung transplant pulmonologist and Assistant Professor Internal Medicine at The Ohio State University. And Pamela Burcham is a lung transplant specialty pharmacist from the OSU Wexner Medical Center.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS indications for immunosuppressive therapies; and DESCRIBE prophylaxis immunization, and pregnancy considerations for patients on Immunosuppressive therapy; UNDERSTAND the indications for individual immunosuppressants; and DESCRIBE the common adverse effects and monitoring parameters of the immunosuppressive medications.

You’ll also learn about the following:

  • Common indications for immunosuppressant medications
  • Commonly used immunosuppressant medications
  • Food safety for patients taking immunosuppressant medications
  • Pneumocystis jiroveci clinical presentation
  • Indications for TNF inhibitors
  • Infection risk of TNF inhibitors
  • Management of immunosuppressants in the perioperative period
  • Travel safety when taking an immunosuppressant
  • Bone health and corticosteroids
  • Eye health and corticosteroids
  • Monitoring for methotrexate-induced hepatotoxicity
  • Thiopurine methylytransferase
  • Cyclophosphamide

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.